More good news
Interesting to note that Daiichi Sanyo gained approval last year to bring an oncolytic virus to market in Japan - the first such approval in Japan. The approval (conditional) was granted on the basis of one single arm ph 2 study with no control group.
https://pharmaphorum.com/news/daiichi-sankyo-claims-first-okay-for-cancer-killing-virus-in-japan/
I have previously suggested Daiichi as a possible partner for Imugene - with regard to Her-Vaxx. Daiichi is trying hard to expand their oncology portfolio. It’s a fair bet they would be interested in CF33 too.
Just a thought. Late night here for me though, so I’m off to bed. Wake me if anything else exciting happens….
Cheers
Dave
More good news :)Interesting to note that Daiichi Sanyo gained...
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3441484 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 574188 | 6 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |